Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,946
datasets available to search
ShareScore release 0.9.0
Dataset results
5,946 results for “Type 2 diabetes”
Microbial Determinants of Dementia Risk in Type 2 Diabetics of Mexican Descent
ClinicalTrials.gov study NCT04602650. IPD Sharing: NO. Countries: 1. Publications: 1.
Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
ClinicalTrials.gov study NCT00331487. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test
ClinicalTrials.gov study NCT01936025. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Validation of an Integrated Attention Model for Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT02836808. IPD Sharing: YES. Countries: 1. Publications: 7.
Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride
ClinicalTrials.gov study NCT03917940. IPD Sharing: NO. Countries: 1. Publications: 3.
A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 Years
ClinicalTrials.gov study NCT01681550. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effects of High and Low GI Breakfasts on Cognitive Performance in Adults With Type 2 Diabetes
ClinicalTrials.gov study NCT01047813. IPD Sharing: Not stated. Countries: 1. Publications: 13.
Effectiveness of a Computerised Prompt for Primary and Secondary Care Physicians to Refer or Refer Back Type 2 Diabetes Patients
ClinicalTrials.gov study NCT02229110. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
ClinicalTrials.gov study NCT01687582. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
ClinicalTrials.gov study NCT01682759. IPD Sharing: YES. Countries: 0. Publications: 1.
Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00101803. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
ClinicalTrials.gov study NCT00976261. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients
ClinicalTrials.gov study NCT03643783. IPD Sharing: NO. Countries: 1. Publications: 19.
A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin The
ClinicalTrials.gov study NCT01755156. IPD Sharing: YES. Countries: 0. Publications: 1.
Effects of Acupuncture as Adjunctive Therapy in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT04829045. IPD Sharing: NO. Countries: 1. Publications: 1.
Observational Study in Japanese Type 2 Diabetes Patients
ClinicalTrials.gov study NCT01055808. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Low Glycemic Index Diet for Type 2 Diabetics
ClinicalTrials.gov study NCT01063374. IPD Sharing: NO. Countries: 1. Publications: 2.
Dapagliflozin Versus Glimepiride Effect in Patient With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT04240171. IPD Sharing: NO. Countries: 1. Publications: 4.
Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT05669599. IPD Sharing: YES. Countries: 12. Publications: 1.
Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00497198. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.